Net asset value of the EfTEN United Property Fund as of 31.08.2024
September 25, 2024 01:15 ET
|
EFTEN UNITED PROPERTY FUND
The net asset value (NAV) of EfTEN United Property Fund unit was 10.66 euros at the end of August, increasing by 0.1% over the month. The somewhat smaller-than-usual increase in NAV was related to the...
Yulin International Coal and High-end Energy Chemicals Industry Expo has Become a High-level Cooperation Platform in the Field of Global Energy
September 25, 2024 01:13 ET
|
Yulin Municipal People's Government
YULIN, China, Sept. 25, 2024 (GLOBE NEWSWIRE) -- From September 13th to 15th, the 18th Yulin International Coal and High-end Energy Chemicals Industry Expo, co-hosted by the Yulin Municipal...
Start of Day Message
September 25, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 25 Sep. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
The electricity system is expanding and becoming more challenging to manage – Fingrid to raise grid service fees at the start of the year
September 25, 2024 01:00 ET
|
Fingrid Oyj
Stock exchange release 25 September 2024 The transmission system operator Fingrid will raise its fees for grid services by eight per cent from the start of 2025. The increase is necessitated by...
Technip Energies and JGC Corporation awarded FEED contract by ExxonMobil for the Rovuma LNG project in Mozambique
September 25, 2024 01:00 ET
|
TECHNIP ENERGIES
Technip Energies (PARIS: TE) and JGC Corporation have been awarded the Front-End Engineering Design (FEED) contract by ExxonMobil – on behalf of Mozambique Rovuma Venture (MRV), a joint venture of...
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
September 25, 2024 01:00 ET
|
Genespire
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic One of the largest private Italian Biotech company financings...
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types
September 25, 2024 01:00 ET
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced new pooled subgroup analysis results from the Phase 3 INTEGUMENT-1 and -2 trials.
OKX Launches 'Unlock OKX: UNLEASHED' Campaign, Featuring a 150,000 USDT Reward Pool
September 25, 2024 00:48 ET
|
OKX
NASSAU, The Bahamas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- OKX, leading crypto exchange and global Web3 technology company, has issued updates for September 25, 2024. OKX Launches 'Unlock OKX:...
While Graduate Degrees Yield the Highest Median Earnings of All Educational Credentials, Costs Have Tripled Since 2000, Georgetown University Report Says
September 25, 2024 00:01 ET
|
Georgetown University Center on Education and the Workforce
Washington, DC, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Higher earnings, lower unemployment rates, career advancement, and a genuine curiosity for learning all drive interest in graduate education, but...
Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
September 24, 2024 23:29 ET
|
Junshi Biosciences
SHANGHAI, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to...